CPI-0610, a bromodomain and extraterminal domain protein (bet) inhibitor, in combination with ruxolitinib, in jak-inhibitor-naive myelofibrosis patients: Update of manifest phase 2 study Meeting Abstract
| Authors: | Mead, A.; Mascarenhas, J.; Talpaz, M.; Patriarca, A.; Devos, T.; Palandri, F.; Passamonti, F.; Rampal, R.; Kremyanskaya, M.; Scandura, J.; Somervaille, T.; Wondergem, M.; Granacher, N.; Hoffman, R.; Gupta, V.; Luptakova, K.; Wang, J.; Christo, J.; Colak, G.; Shao, J.; Bobba, S.; Trojer, P.; Verstovsek, S.; Harrison, C. |
| Abstract Title: | CPI-0610, a bromodomain and extraterminal domain protein (bet) inhibitor, in combination with ruxolitinib, in jak-inhibitor-naive myelofibrosis patients: Update of manifest phase 2 study |
| Meeting Title: | 61st Annual Scientific Meeting of the British Society for Haematology |
| Journal Title: | British Journal of Haematology |
| Volume: | 193 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Apr 25-28 |
| Meeting Location: | Virtual |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2021-04-01 |
| Start Page: | 96 |
| Language: | English |
| ACCESSION: | WOS:000645412200112 |
| PROVIDER: | wos |
| PUBMED: | 33928641 |
| DOI: | 10.1111/bjh.17492 |
| Notes: | Meeting Abstract: BSH2021-PO-068 -- Source: Wos |
